Category: Press Release - Page 9 - Psychedelic Alpha

Read more about the article Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psilocybin

Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psilocybin

Post published:July 13, 2023
Post category:Press Release

Read more about the article Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine’s Scientific Advisory Board

Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine’s Scientific Advisory Board

Post published:July 11, 2023
Post category:Press Release

Read more about the article Psyence Appoints Intellectual Property Expert to Its Board of Directors

Psyence Appoints Intellectual Property Expert to Its Board of Directors

Post published:July 11, 2023
Post category:Press Release

Read more about the article Bright Minds Announces Effective Date of Share Consolidation

Bright Minds Announces Effective Date of Share Consolidation

Post published:July 11, 2023
Post category:Press Release

Read more about the article Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023

Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023

Post published:July 11, 2023
Post category:Press Release

Read more about the article American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies

American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies

Post published:July 6, 2023
Post category:Press Release

Read more about the article Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Post published:July 6, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH TO SUPPLY PSILOCYBIN FOR RECIPIENTS OF THE CANADIAN INSTITUTES OF HEALTH RESEARCH PSILOCYBIN OPERATING GRANTS

FILAMENT HEALTH TO SUPPLY PSILOCYBIN FOR RECIPIENTS OF THE CANADIAN INSTITUTES OF HEALTH RESEARCH PSILOCYBIN OPERATING GRANTS

Post published:July 6, 2023
Post category:Press Release

Read more about the article COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital

COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital

Post published:July 5, 2023
Post category:Press Release

Read more about the article Small Pharma Announces SPL028 R&D Strategy Update

Small Pharma Announces SPL028 R&D Strategy Update

Post published:July 5, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.